Diabetes drug may protect breast cancer Patients' uterus
NCT ID NCT07145827
First seen Nov 01, 2025 · Last updated May 01, 2026 · Updated 21 times
Summary
This study tested whether metformin, a common diabetes medicine, can reduce the thickening of the uterine lining caused by tamoxifen in postmenopausal women with estrogen-positive breast cancer. Sixty women who had been taking tamoxifen for at least a year were randomly assigned to add either metformin or a placebo. Researchers measured uterine lining thickness with ultrasound over 12 months to see if metformin made a difference.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for BREAST CANCER are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Locations
-
Baghdad Medical City / Department of Oncology
Baghdad, Baghdad Governorate, 10045, Iraq
Conditions
Explore the condition pages connected to this study.